Regency Centers (NYSE:REG) Shares Were Upgraded Today by BidaskScore

Regency Centers Corporation (NASDAQ:REG) Logo

Investors sentiment decreased to 0.88 in 2018 Q4. Its down 0.51, from 1.39 in 2018Q3. It is negative, as 35 investors sold Regency Centers Corporation shares while 112 reduced holdings. 27 funds opened positions while 103 raised stakes. 160.94 million shares or 0.72% less from 162.11 million shares in 2018Q3 were reported.

Moreover, Schroder Investment Mngmt Grp Inc Incorporated has 0% invested in Regency Centers Corporation (NASDAQ:REG) for 17,842 shares. Valley National Advisers has 0.01% invested in Regency Centers Corporation (NASDAQ:REG). Regions Fin reported 0% in Regency Centers Corporation (NASDAQ:REG). Ftb Advisors holds 0% or 204 shares in its portfolio. Aqr Ltd Liability owns 0% invested in Regency Centers Corporation (NASDAQ:REG) for 32,276 shares. Parallax Volatility Advisers L P invested 0% of its portfolio in Regency Centers Corporation (NASDAQ:REG). Gateway Investment Advisers Ltd Liability owns 372,335 shares. Prelude Cap Limited Liability Company holds 0.03% or 6,966 shares. Employees Retirement System Of Ohio holds 0.08% or 243,538 shares in its portfolio. 34,374 were reported by Amica Mutual Insur Communication. Adelante Cap Mngmt Lc holds 1.06M shares. Phocas Corp holds 0.11% or 16,495 shares in its portfolio. Morgan Stanley holds 0.05% or 2.75 million shares in its portfolio. Estabrook Mngmt has invested 0% in Regency Centers Corporation (NASDAQ:REG). Csat Advisory L P reported 0.01% stake.

Regency Centers (NYSE:REG) Stock Upgrade

Trading of shares of Regency Centers (NYSE:REG) will be interesting to watch this afternoon as BidaskScore increased the stock to a “Hold”.

Regency Centers Corporation (NASDAQ:REG) Ratings Coverage

Among 5 analysts covering Regency Centers (NYSE:REG), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Regency Centers has $75 highest and $69 lowest target. $71.50’s average target is 8.35% above currents $65.99 stock price. Regency Centers had 9 analyst reports since December 14, 2018 according to SRatingsIntel. SunTrust maintained the shares of REG in report on Friday, February 22 with “Buy” rating. The firm has “Outperform” rating by RBC Capital Markets given on Friday, December 14. The stock of Regency Centers Corporation (NASDAQ:REG) has “Buy” rating given on Friday, February 22 by Citigroup. BTIG Research maintained the shares of REG in report on Thursday, March 14 with “Buy” rating. The firm earned “Overweight” rating on Monday, February 4 by Barclays Capital.

The stock increased 0.69% or $0.45 during the last trading session, reaching $65.99. About 1.00 million shares traded or 35.41% up from the average. Regency Centers Corporation (NYSE:REG) has risen 10.61% since May 14, 2018 and is uptrending. It has outperformed by 6.24% the S&P500.

Analysts await Regency Centers Corporation (NASDAQ:REG) to report earnings on August, 1. They expect $0.96 EPS, up 3.23 % or $0.03 from last year’s $0.93 per share. REG’s profit will be $160.77 million for 17.18 P/E if the $0.96 EPS becomes a reality. After $0.98 actual EPS reported by Regency Centers Corporation for the previous quarter, Wall Street now forecasts -2.04 % negative EPS growth.

Regency Centers Corporation operates as a real estate investment trust. The company has market cap of $11.05 billion. The company, through its subsidiaries, owns, operates, and develops community and neighborhood shopping centers that are tenanted by grocers, category-leading anchors, specialty retailers, and restaurants. It has a 39.07 P/E ratio. As of December 31, 2006, it owned 218 retail shopping centers located in 22 states and held partial interests in 187 retail shopping centers through joint ventures located in 24 states and the District of Columbia.

More notable recent Regency Centers Corporation (NASDAQ:REG) news were published by: which released: “DNA Brands Ridesharing Fleet Hits the Roads – Second Round of Purchasing Commences – Nasdaq” on May 13, 2019, also with their article: “Cantargia Announces New Pre-clinical Results Showing Consistent Positive Effects of the Antibody CAN04 When Combined with Platinum-based Chemotherapies – Yahoo Finance” published on May 14, 2019, published: “Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS – Nasdaq” on April 24, 2019. More interesting news about Regency Centers Corporation (NASDAQ:REG) were released by: and their article: “Nasdaq Wants To Raise The Bar For Reg A+ Listings – Law360” published on April 18, 2019 as well as‘s news article titled: “TruCrowd, Inc. Family of Portals Provides Market Recap and Update – Nasdaq” with publication date: May 08, 2019.

Regency Centers Corporation (NASDAQ:REG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.